Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$381K Sell
37,110
-27,707
-43% -$205K ﹤0.01% 1785
2023
Q4
$537K Sell
64,817
-36,477
-36% -$262K 0.01% 1087
2023
Q3
$633K Buy
+101,294
New +$439K 0.01% 934
2021
Q3
Sell
-24,880
Closed -$293K 1447
2021
Q2
$293K Buy
+24,880
New +$286K 0.01% 1058

Other funds holding LFMD

Cetera Advisors's LFMD Position: Q1 2024 in Review

Cetera Advisors reduced its LifeMD (LFMD) stake by 43% in Q1 2024, selling an estimated $205K and leaving 37,110 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Cetera Advisors first reported a position in LFMD in Q2 2021 and has held it in 4 quarters since. The position peaked at $633K in Q3 2023. 89 funds tracked by Wall St. Rank hold LFMD as of Q1 2024.

  • Cetera Advisors held 37,110 shares of LifeMD worth $381K as of Q1 2024.
  • Cetera Advisors sold 27,707 LifeMD shares in Q1 2024, an estimated $205K.
  • LifeMD made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1785 holding.
  • Cetera Advisors first reported a position in LifeMD in Q2 2021 and has held it in 4 quarters since.
  • Cetera Advisors's LifeMD position peaked at $633K in Q3 2023.
  • 89 funds tracked by Wall St. Rank held LifeMD as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.